A new IHME report, The State of US Health: Innovations, Insights, and Recommendations from the Global Burden of Disease Study, published in July, boosted the ability of first lady Michelle Obama’s Let’s Move! campaign to help communities address obesity nationwide.
How many years are lost to HIV/AIDS in lives cut short or lived in disability? How much progress have countries made in fighting this disease? Decision-makers need answers to these questions. A new study by IHME researchers found that the scale-up of antiretroviral therapy and prevention programs has contributed to significant progress in reducing premature death and disability around the world.
Over the past few months, IHME’s leaders have presented our GBD work at events spanning the globe, from Washington, DC, to Beijing. And we continue to grow as an organization, welcoming new faculty members and fellows. Here is a recap of recent events.
In June 2013, the World Health Organization released new guidelines for treating HIV-positive patients: antiretroviral therapy (ART) initiation should start at earlier stages of disease progression, and testing of viral load, a measure of how much HIV is in a patient’s blood, is now strongly recommended for monitoring ART effectiveness even in low-resource settings. For IHME, these changes complement the launch of a new evaluation project known as the Viral Load Pilot study.
The change in percent of females reporting sufficient physical activity by county, 2001-2009.
The Global Burden of Disease Study 2010 continues to provide a strong foundation for further research. Several country- and region-specific GBD analyses have been published this year, focusing in as closely as the county level for the US. IHME’s work in data modeling was represented in print as well.